360 filings
Page 7 of 18
8-K
PHASQ
PhaseBio Pharmaceuticals Inc
4 Jun 21
Submission of Matters to a Vote of Security Holders
5:00pm
4
John P Sharp
24 May 21
PhaseBio Pharmaceuticals / John P Sharp ownership change
6:11pm
4
Glen Burkhardt
24 May 21
PhaseBio Pharmaceuticals / Glen Burkhardt ownership change
6:11pm
4
Jonathan P Mow
24 May 21
PhaseBio Pharmaceuticals / Jonathan P Mow ownership change
6:10pm
4
Michael York
24 May 21
PhaseBio Pharmaceuticals / Michael York ownership change
6:10pm
4
PHASQ
PhaseBio Pharmaceuticals Inc
24 May 21
PhaseBio Pharmaceuticals / Susan Elizabeth Arnold ownership change
6:09pm
4
Kristopher Hanson
24 May 21
PhaseBio Pharmaceuticals / Kristopher Hanson ownership change
6:09pm
SC 13G
PHASQ
PhaseBio Pharmaceuticals Inc
19 May 21
PhaseBio Pharmaceuticals / Rosalind Advisors ownership change
2:25pm
10-Q
2021 Q1
PHASQ
PhaseBio Pharmaceuticals Inc
Quarterly report
13 May 21
4:14pm
8-K
PHASQ
PhaseBio Pharmaceuticals Inc
13 May 21
PhaseBio Reports First-Quarter 2021 Financial Results and Recent Business Highlights
4:06pm
DEF 14A
PHASQ
PhaseBio Pharmaceuticals Inc
Definitive proxy
29 Apr 21
12:00am
SC 13G
PHASQ
PhaseBio Pharmaceuticals Inc
24 Mar 21
PhaseBio Pharmaceuticals / RA CAPITAL MANAGEMENT ownership change
4:30pm
SC 13G
Avidity Partners Management LP
22 Mar 21
PhaseBio Pharmaceuticals / Avidity Partners Management ownership change
4:05pm
8-K
PHASQ
PhaseBio Pharmaceuticals Inc
19 Mar 21
PhaseBio Announces Pricing of Public Offering of Common Stock
4:08pm
424B5
PHASQ
PhaseBio Pharmaceuticals Inc
19 Mar 21
Prospectus supplement for primary offering
4:04pm
424B5
PHASQ
PhaseBio Pharmaceuticals Inc
17 Mar 21
Prospectus supplement for primary offering
5:07pm
S-8
PHASQ
PhaseBio Pharmaceuticals Inc
15 Mar 21
Registration of securities for employees
8:42am
10-K
2020 FY
PHASQ
PhaseBio Pharmaceuticals Inc
Annual report
15 Mar 21
8:18am
8-K
PHASQ
PhaseBio Pharmaceuticals Inc
15 Mar 21
PhaseBio Reports Fourth-Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
8:10am
8-K
PHASQ
PhaseBio Pharmaceuticals Inc
11 Mar 21
PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of Bentracimab
8:08am